De-methylation of displacement loop of mitochondrial DNA is associated with increased mitochondrial copy number and nicotinamide adenine dinucleotide subunit 2 expression in colorectal cancer

Molecular Medicine Reports

Volumn 12, Issue 5, 2015, Pages 7033-7038

  Gao, Jinhang ^a,b   Wen, Shilei ^a   Zhou, Hongying ^a   Feng, Shi ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Caco 2; Colorectal cancer; De methylation; Displacement loop; Mitochondrial DNA; Nicotinamide adenine dinucleotide subunit 2

Indexed keywords

CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE SUBUNIT 2; UNCLASSIFIED DRUG; NADH DEHYDROGENASE SUBUNIT 2, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ARTICLE; CACO 2 CELL LINE; CELL CULTURE; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; COPY NUMBER VARIATION; DEMETHYLATION; DNA METHYLATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; WESTERN BLOTTING; ADULT; AGED; CANCER STAGING; COLORECTAL TUMOR; GENETICS; METABOLISM; MIDDLE AGED; MITOCHONDRION; PATHOLOGY;

ADULT; AGED; CACO-2 CELLS; COLORECTAL NEOPLASMS; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; NADH DEHYDROGENASE; NEOPLASM STAGING;

EID: 84943604327     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4256     Document Type: Article

References (23)

1. Siegel R, Desantis C and Jemal A: Colorectal cancer statistics, 2014. CA Cancer J Clin 64: 104-117, 2014.
2. Center MM, Jemal A, Smith RA and Ward E: Worldwide variations in colorectal cancer. CA Cancer J Clin 59: 366-378, 2009.
3. Grivell LA: Mitochondrial DNA. Small, beautiful and essential. Nature 341: 569-571, 1989.
4. Lightowlers RN, Chinnery PF, Turnbull DM and Howell N: Mammalian mitochondrial genetics: Heredity, heteroplasmy and disease. Trends Genet 13: 450-455, 1997.
5. Zhang G, Qu Y, Dang S, Yang Q, Shi B and Hou P: Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients. Diagn Pathol 8: 173, 2013.
6. Cheau-Feng Lin F, Jeng YC, Huang TY, Chi CS, Chou MC and Chin-Shaw Tsai S: Mitochondrial DNA copy number is associated with diagnosis and prognosis of head and neck cancer. Biomarkers 19: 269-274, 2014.
7. Feng S, Xiong L, Ji Z, Cheng W and Yang H: Correlation between increased copy number of mitochondrial DNA and clinicopathological stage in colorectal cancer. Oncol Lett 2: 899-903, 2011.
8. Boland ML, Chourasia AH and Macleod KF: Mitochondrial dysfunction in cancer. Front Oncol 3: 292, 2013.
9. Feng S, Xiong L, Ji Z, Cheng W and Yang H: Correlation between increased ND2 expression and demethylated displacement loop of mtDNA in colorectal cancer. Mol Med Rep 6: 125-130, 2012.
10. Bellizzi D, D'Aquila P, Scafone T, Giordano M, Riso V, Riccio A and Passarino G: The control region of mitochondrial DNA shows an unusual CpG and non-CpG methylation pattern. DNA Res 20: 537-547, 2013.
11. Roos-Araujo D, Stuart S, Lea RA, Haupt LM and Griffiths LR: Epigenetics and migraine; complex mitochondrial interactions contributing to disease susceptibility. Gene 543: 1-7, 2014.
12. Esteller M: CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene 21: 5427-5440, 2002.
13. Mates IN, Jinga V, Csiki IE, Mates D, Dinu D, Constantin A and Jinga M: Single nucleotide polymorphisms in colorectal cancer: associations with tumor site and TNM stage. J Gastrointestin Liver Dis 21: 45-52, 2012.
14. Matsubara N: Epigenetic regulation and colorectal cancer. Dis Colon Rectum 55: 96-104, 2012.
15. Zhang R, Zhang F, Wang C, Wang S, Shiao YH and Guo Z: Identification of sequence polymorphism in the D-Loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology. J Exp Clin Cancer Res 29: 130, 2010.
16. Ylikallio E, Tyynismaa H, Tsutsui H, Ide T and Suomalainen A: High mitochondrial DNA copy number has detrimental effects in mice. Hum Mol Genet 19: 2695-2705, 2010.
17. Penta JS, Johnson FM, Wachsman JT and Copeland WC: Mitochondrial DNA in human malignancy. Mutat Res 488: 119-133, 2001.
18. Zhang J, Guo Z, Bai Y, Cui L, Zhang S and Xu J: Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for renal cell carcinoma. Biomed Rep 1: 563-566, 2013.
19. Tommasi S, Favia P, Weigl S, Bianco A, Pilato B, Russo L, Paradiso A and Petruzzella V: Mitochondrial DNA variants and risk of familial breast cancer: An exploratory study. Int J Oncol 44: 1691-1698, 2014.
20. Maniura-Weber K, Goffart S, Garstka HL, Montoya J and Wiesner RJ: Transient overexpression of mitochondrial transcription factor A (TFAM) is sufficient to stimulate mitochondrial DNA transcription, but not sufficient to increase mtDNA copy number in cultured cells. Nucleic Acids Res 32: 6015-6027, 2004.
21. Kurita T, Izumi H, Kagami S, Kawagoe T, Toki N, Matsuura Y, Hachisuga T and Kohno K: Mitochondrial transcription factor A regulates BCL2L1 gene expression and is a prognostic factor in serous ovarian cancer. Cancer Sci 103: 239-444, 2012.
22. LeBleu VS, O'Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC, de Carvalho FM, Damascena A, Domingos Chinen LT, Rocha RM, et al: PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol 16: 992-1003, 2014.
23. Lim SH, Wu L, Kiew LV, Chung LY, Burgess K and Lee HB: Rosamines targeting the cancer oxidative phosphorylation pathway. PloS one 9: e82934, 2014.